BRIEF-Neovasc says jury found in favor of CardiAQ on relief for contract breach
May 19 (Reuters) - Neovasc Inc
* Jury found in favor of CardiAQ, on claims for relief for breach of contract, breach of duty of honesty in contractual performance
* Says jury awarded $70 million on trade secret claim for relief, and no damages on contractual claims for relief
* Jury issued advisory findings in favor of CardiAQ regarding its causes of action under Massachusetts Gen. Law. Ch. 93A & patent inventorship
* Alexei Marko, Neovasc CEO said will be exploring our options regarding post-trial motions in trial court potentially, appellate process Source text for Eikon: Further company coverage: (Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223 8780)
© Thomson Reuters 2017 All rights reserved.